Cannabis Group Weekly Alert - June 2019

Dentons
Contact

Dentons

Last week, Illinois passed a bill that, when signed by Governor Pritzker, will make the state the 11th to legalize cannabis for adult use, and the first to do so by legislation rather than voter referendum. While adult-use legalization appears to be dead for now in Connecticut, New Jersey and New York, bills in New Jersey and Texas to expand their medical cannabis programs both progressed. And across the pond, France announced a medical cannabis pilot program.

In hemp and CBD news, the USDA issued two memorandums regarding hemp legalization, and on May 31st, the FDA held its first public hearing on the effects of CBD. Public comment on the topic remains open until July 2nd.

See below to read more about these and other cannabis-related stories. In separate Alerts this week, we provide a more detailed look at the Illinois adult use legislation and our takeaway from the FDA hearing

Federal

The US Department of Agriculture issued two memos on hemp legalization implementation, clarifying some points of contention in the industry. The USDA stated its opinion that: (i) descheduling of the crop and its derivatives, such as CBD and THC, is self-executing without further action; and (ii) that states cannot block legal hemp shipments through their borders, including for hemp grown legally pursuant to the 2014 Farm Bill. The memos also clearly state that the trace amounts of THC found in hemp are no longer considered a controlled substance: “Congress has removed hemp from Schedule I and removed it entirely from the CSA. In other words, hemp is no longer a controlled substance. Also, by amending Schedule I to exclude THC in hemp, Congress has likewise removed THC in hemp from the CSA.”

The US Food and Drug Administration (FDA) held its much anticipated public hearing on products containing cannabis or cannabis-derived compounds on Friday, May 31st. FDA Commissioner Dr. Ned Sharpless gave opening remarks that mirrored prior public FDA statements. His prepared remarks are available here. Attorneys from Dentons’ Cannabis group attended the event and have provided a high-level summary here.

Twelve governors (seven Democrats and five Republicans) of states with laws permitting or decriminalizing marijuana for adult use or medical purposes delivered a letter urging Congress to pass the “Strengthening the Tenth Amendment Through Entrusting States (STATES) Act,” calling it a “logical step” that “honors state action by codifying protection at the federal level for those businesses and consumers operating in accordance with state law.”

The US Court of Appeals for the Second Circuit issued an opinion keeping open a challenge to cannabis’s Schedule I status and warning that it may take matters into its own hands if the Drug Enforcement Administration doesn’t “promptly” consider medical cannabis patients’ rescheduling requests. Noting the DEA’s history of “dilatory proceedings,” the Court suggested that may have to take more drastic action if the DEA declines to take action or delays its decision on rescheduling.

States

The Arizona Supreme Court ruled that medical cannabis extracts are legal. Although the Yavapai County Attorney argued that the Arizona Medical Marijuana Act only permits cannabis flower, the Court reasoned that a plain reading of the act compelled its finding that patients were allowed to consume cannabis in various forms.

Colorado’s Governor signed several cannabis bills including HB 1090, which permits investments by individuals and entities outside CO and public companies, HB 1230, which allows for cannabis tasting rooms, and HB 1234, which allows for home delivery.

Connecticut's House speaker Joe Aresimowicz (D) said that cannabis legalization is dead for the year. At this point, lawmakers are considering putting the issue of legalization in front of the state’s voters in the form of a Constitutional amendment.

The Illinois legislature passed HB 1438, a bill to allow for adult use in Illinois starting in 2020. Illinois will become the 11th state to legalize adult use and the first to do so through its legislature rather than a ballot referendum. The bill now goes to the desk of Gov. J.B. Pritzker (D), who tweeted his intention to sign it into law. Highlights of the 533-page bill, written by lawyers in Dentons’ Cannabis practice group, are available here.

Iowa Gov. Kim Reynolds (R) vetoed a bill to expand the state's limited CBD medical cannabis program. Reynolds took issue with a provision that would have increased the amount of THC allowable in medical products, from 3 percent THC per product to a 25mg THC limit per month. She stated: “I agree that there should be some change to the three percent THC limit . . . [b]ut I have not been unable to discern any evidence-based justification for the specific 25-gram limit proposed in this bill.”

The Louisiana Senate killed a bill that would have added inhalation to the list of permitted methods for patients to administer medical cannabis.

Maryland regulators received more than 160 applications for 14 available medical cannabis business licenses.

Missouri regulators issued final rules for its medical cannabis program. Under the rules, applications will begin to be accepted August 3, 2019; those received on that date will be approved or denied within 150 days (by Dec. 31, 2019). Licenses will be valid for 3 years.

The New Jersey Senate passed its version of a medical cannabis expansion bill. A new vote by the House to align with a last-minute amendment the Senate approved is expected on June 10. Separately, the NJ Department of Health is seeking new alternative treatment centers to expand access to medical cannabis. The department may add up to 108 new centers.

Texas lawmakers took final action on a medical cannabis expansion bill, sending it to the desk of Gov. Greg Abbott (R), who is expected to sign it. The bill eliminates the need for patients to get approval from two specialists in order to participate and adds several conditions, including terminal cancer, incurable neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s, Huntington’s, etc.), autism, ALS, all epilepsy disorders, multiple sclerosis and spasticity.

Utah regulators have begun accepting medical cannabis cultivation license applications. The window to submit proposals to the state opened on May 31 and closes on July 1.

Hemp and CBD

Nebraska lawmakers passed a hemp bill. LB657 requires the state Department of Agriculture to establish, operate and administer a program to license and regulate those who cultivate, process, handle or broker hemp. The bill expressly permits the possession, transport and sale of hemp products.

International

Pending approval by its Ministry of Health, France is set to launch a multi-year medical cannabis pilot program. The use of medical cannabis will be strictly controlled. Only a small number of patients will be eligible to receive it and only as “a last resort” after trying other available therapeutic pain treatments.

Business

After Google announced that it is banning from its Google Play Store Android-friendly apps that “facilitate the sale of marijuana,” a company spokesperson told Marijuana Moment that affected apps can remain on the platform simply by “mov[ing] the shopping cart flow outside of the app itself.”

Even as Square moves to allow CBD companies onto its credit card-processing platform, eBay says it will continue to ban people from selling products containing the cannabis-derived compound.

Charlotte's Web Holdings, Inc., announced that it will trade on the Toronto Stock Exchange. This occurred on the heels of its having reported year-over-year revenue growth of 66 percent, despite a year-over-year decrease in net income.

Breath of Life International Ltd. (BOL Pharma), Israel’s largest medical cannabis producer, has filed a preliminary prospectus for a proposed IPO on the Toronto Stock Exchange.

Acreage Holdings, Inc., reported a 487 percent increase in quarterly revenue from a year ago, but it also incurred net losses of more than $31 million.

Cresco Labs reported earnings that were lower than Wall Street expectations ($21.1 million vs. estimated $22.8 million). Year-over-year revenue increased 313 percent.

Rohrabacher announced on Twitter that he has become a shareholder and advisory board member of BudTrader, an online advertising platform for cannabis products, services, jobs, equipment and more.

Health

Researchers from the University of Colorado compared in-hospital outcomes of acute myocardial infarctions (AMI) patients with reported cannabis use to those with no reported cannabis use and found that cannabis use was not associated with increased risk of adverse short-term outcomes. Furthermore, cannabis use was associated with decreased in-hospital mortality post-AMI. Although the study had several limitations (including its reliance on self-reported cannabis use and a lack of information on frequency or dosing), researchers surmise cannabis may have cardiac protective effects.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Dentons | Attorney Advertising

Written by:

Dentons
Contact
more
less

Dentons on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.